Neumora Therapeutics Inc (NASDAQ: NMRA) kicked off on Monday, up 9.77% from the previous trading day, before settling in for the closing price of $2.56. Over the past 52 weeks, NMRA has traded in a range of $0.61-$14.09.
While this was happening, its average annual earnings per share was recorded 6.06%. With a float of $54.09 million, this company’s outstanding shares have now reached $161.95 million.
Neumora Therapeutics Inc (NMRA) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Neumora Therapeutics Inc is 67.63%, while institutional ownership is 21.20%. The most recent insider transaction that took place on Oct 27 ’25, was worth 4,999,977. In this transaction Director of this company bought 1,915,700 shares at a rate of $2.61, taking the stock ownership to the 6,046,907 shares. Before that another transaction happened on Oct 27 ’25, when Company’s 10% Owner bought 1,915,700 for $2.61, making the entire transaction worth $4,999,977. This insider now owns 6,046,907 shares in total.
Neumora Therapeutics Inc (NMRA) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.37 earnings per share (EPS), higher than consensus estimate (set at -0.44) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
Neumora Therapeutics Inc (NASDAQ: NMRA) Trading Performance Indicators
Take a look at Neumora Therapeutics Inc’s (NMRA) current performance indicators. Last quarter, stock had a quick ratio of 6.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.04 in one year’s time.
Technical Analysis of Neumora Therapeutics Inc (NMRA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.84 million. That was inferior than the volume of 1.9 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 33.70%.
During the past 100 days, Neumora Therapeutics Inc’s (NMRA) raw stochastic average was set at 82.64%, which indicates a significant increase from 72.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was higher than the 0.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.99, while its 200-day Moving Average is $1.42. However, in the short run, Neumora Therapeutics Inc’s stock first resistance to watch stands at $2.97. Second resistance stands at $3.13. The third major resistance level sits at $3.34. If the price goes on to break the first support level at $2.60, it is likely to go to the next support level at $2.39. The third support level lies at $2.23 if the price breaches the second support level.
Neumora Therapeutics Inc (NASDAQ: NMRA) Key Stats
The company with the Market Capitalisation of 469.52 million has total of 161,945K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -243,790 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -52,730 K.
